Clinical trial
Combination of Telmisartan and Simvastatin in the Treatment of Hypertension and…
NCT00316095 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00316095 |
|---|---|
| Title | Combination of Telmisartan and Simvastatin in the Treatment of Hypertension and Hypercholesterolemia |
| Official title | Reduced Factorial Design, Randomized, Double Blind Trial Comparing Combinations of Telmisartan 20 or 80 mg and Simvastatin 20 or 40 mg With Single Component Therapies in the Treatment of Hypertension and Dyslipidemia |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension, Dyslipidemias |
| Intervention type | Drug |
| Interventions | telmisartan, simvastatin |
| Enrollment | 1,695 |
| Start date | Apr 1, 2006 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Apr 20, 2006 |
| Last update posted | Nov 1, 2013 |
| Countries | Czechia, France, Germany, Hong Kong, Netherlands, Russia, Slovakia, South Africa, South Korea, Sweden, Taiwan, Ukraine |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: